24136988 |
The molecular balancing act of p16(INK4a) in cancer and aging
Burd, CE,
LaPak, KM
|
Mol. Cancer Res. |
2014 |
10391689 |
High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats
Hiai, H,
Iwasa, Y,
Toyokuni, S,
Tanaka, T,
Kondo, S
|
Oncogene |
1999 |
26105537 |
Forging a signature of in vivo senescence
Sharpless, NE,
Sherr, CJ
|
Nat. Rev. Cancer |
2015 |
8589035 |
Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas
Tung, WS,
Shevlin, DW,
Bartsch, D,
Goodfellow, PJ,
Wells, SA,
Kisker, O
|
Genes Chromosomes Cancer |
1995 |
18538737 |
Mitochondrial p32 is a critical mediator of ARF-induced apoptosis
Itahana, K,
Zhang, Y
|
Cancer Cell |
2008 |
27846439 |
A new role for oxidative stress in aging: The accelerated aging phenotype in Sod1-/- mice is correlated to increased cellular senescence
Unnikrishnan, A,
Zhang, Y,
Richardson, A,
Ikeno, Y,
Li, Y,
Van Remmen, H,
Liu, Y,
Deepa, SS,
Sosnowska, D
|
Redox Biol |
2017 |
26997276 |
Evasion of Cell Senescence Leads to Medulloblastoma Progression
Charron, F,
Bouchard, N,
Remke, M,
Wu, CL,
Taylor, MD,
Skowron, P,
Khedher, A,
Swikert, SM,
Tamayo-Orrego, L
|
Cell Rep |
2016 |
9916806 |
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
Dilworth, D,
Lassam, N,
Summers, A,
Monzon, J,
Liu, L,
Gao, L,
Hogg, D
|
Nat. Genet. |
1999 |
10498896 |
Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information
Peters, G,
McDonald, NQ,
Ruas, M,
Brookes, S
|
Oncogene |
1999 |
10854221 |
INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene
Hernández, S,
Nadal, A,
Campo, E,
Hernández, L,
Nayach, I,
Martínez, A,
Pinyol, M,
Montserrat, E,
Fernández, PL,
Cardesa, A,
Palacín, A,
López-Guillermo, A,
Beà, S,
Cobo, F
|
Am. J. Pathol. |
2000 |
10911952 |
Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints
Chen, QM
|
Ann. N. Y. Acad. Sci. |
2000 |
10541552 |
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, CM,
Weber, JD,
Sherr, CJ,
Roussel, MF,
Cleveland, JL
|
Genes Dev. |
1999 |
20473920 |
Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review
Ogino, S,
Meyerhardt, JA,
Baba, Y,
Fuchs, CS,
Cantor, M,
Nosho, K,
Giovannucci, EL,
Shima, K
|
Int. J. Cancer |
2011 |
8153634 |
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A,
Day, RS,
Skolnick, MH,
Weaver-Feldhaus, J,
Stockert, E,
Gruis, NA,
Tavtigian, SV,
Johnson, BE,
Liu, Q,
Harshman, K
|
Science |
1994 |
10360174 |
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
Zhang, Y,
Xiong, Y
|
Mol. Cell |
1999 |
15937071 |
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
Avril, MF,
Demenais, F,
Chaudru, V,
Marian, C,
Lenoir, GM,
Chompret, A,
Laud, K,
Spatz, A,
Bressac-de Paillerets, B,
Peters, G,
Goldstein, AM,
Smith, MW,
Tucker, MA,
Clark, PA,
Barrois, M
|
J. Med. Genet. |
2006 |
11485924 |
Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas
Blaschke, B,
Meyer-Puttlitz, B,
Wolter, M,
Lichter, P,
Weber, RG,
Boström, J,
Reifenberger, G,
Collins, VP,
Ichimura, K
|
Am. J. Pathol. |
2001 |
10541553 |
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
de Stanchina, E,
Wallace-Brodeur, RR,
McCurrach, ME,
Lowe, SW,
Schmitt, CA
|
Genes Dev. |
1999 |
7553622 |
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
Jones, PA,
Gonzalez-Zulueta, M,
Van Tornout, JM,
Beart, RW,
Nguyen, T,
Bender, CM,
Yang, AS
|
Cancer Res. |
1995 |
22019631 |
Tumor suppressor genes and ROS: complex networks of interactions
Poli, G,
Vurusaner, B,
Basaga, H
|
Free Radic. Biol. Med. |
2012 |
11726555 |
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees
Bishop, JA,
Mistry, S,
Harland, M,
Bishop, DT
|
Hum. Mol. Genet. |
2001 |
20838381 |
The p16(INK4A) tumor suppressor regulates cellular oxidative stress
Cassidy, P,
Boucher, KM,
Leachman, SA,
Jenkins, NC,
Goodson, AG,
Liu, T,
Samadashwily, G,
Grossman, D
|
Oncogene |
2011 |
9354451 |
CDKN2A/p16 is inactivated in most melanoma cell lines
Sparrow, LE,
Gabrielli, BG,
Parsons, PG,
Pollock, PM,
Castellano, M,
Walters, MK,
Down, LM,
Hayward, NK
|
Cancer Res. |
1997 |
7553621 |
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
Davidson, NE,
Baylin, SB,
Lapidus, RG,
Merlo, A,
Herman, JG,
Sidransky, D,
Mao, L,
Issa, JPJ
|
Cancer Res. |
1995 |
11477665 |
Mutation analysis of the CDKN2A promoter in Australian melanoma families
Palmer, JM,
Hayward, NK,
Stark, MS,
Martin, NG,
Pollock, PM,
Aitken, JF,
Walters, MK
|
Genes Chromosomes Cancer |
2001 |
9205067 |
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
Reid, BJ,
Stöger, R,
Wong, DJ,
Emond, MJ,
Barrett, MT
|
Cancer Res. |
1997 |
15377661 |
Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts
Chen, JH,
Williams, GH,
Kingsbury, S,
Hales, CN,
Ozanne, SE,
Stoeber, K
|
J. Biol. Chem. |
2004 |
23190892 |
Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions
Jenkins, NC,
Holmen, SL,
Grossman, D,
Liu, T,
Jung, J,
Wilde, M
|
J. Invest. Dermatol. |
2013 |
20016279 |
Tumor suppression by ARF: gatekeeper and caretaker
Brauer, PM,
Chen, YJ,
Raychaudhuri, P,
Pimkina, J,
Dominguez-Brauer, C
|
Cell Cycle |
2010 |
7585152 |
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Burger, PC,
Lee, DJ,
Baylin, SB,
Herman, JG,
Merlo, A,
Sidransky, D,
Gabrielson, E,
Mao, L
|
Nat. Med. |
1995 |
15761864 |
Intronic sequence variants of the CDKN2A gene in melanoma pedigrees
Randerson-Moor, JA,
Mann, GJ,
Bass, S,
Churchman, M,
Bishop, DT,
Taylor, CF,
Newton Bishop, JA,
Holland, EA,
Harland, M
|
Genes Chromosomes Cancer |
2005 |
21775818 |
The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments
Witkiewicz, AK,
Dicker, AP,
Knudsen, ES,
Knudsen, KE
|
Cell Cycle |
2011 |